(Q39694589)

14 September 2017

IL-15 has innate anti-tumor activity independent of NK and CD8 T cells (English)

1 reference

14 September 2017

Elizabeth Davies

1

1 reference

14 September 2017

Sarah Reid

2

1 reference

14 September 2017

Maria Fe Medina

3

1 reference

14 September 2017

Brian Lichty

4

1 reference

14 September 2017

Ali A Ashkar

5

1 reference

14 September 2017

10 June 2010

1 reference

Journal of Leukocyte Biology

14 September 2017

1 reference

14 September 2017

88

1 reference

14 September 2017

3

1 reference

14 September 2017

529-536

1 reference

Cancer immunoediting: from immunosurveillance to tumor escape

14 September 2017

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Natural killer cell activation receptors in innate immunity to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Human natural killer cells: their origin, receptors and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Natural killer cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Distinct cell types control lymphoid subset development by means of IL-15 and IL-15 receptor alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Interleukin (IL)-15Rα–deficient Natural Killer Cells Survive in Normal but Not IL-15Rα–deficient Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

IL-15 transpresentation augments CD8+ T cell activation and is required for optimal recall responses by central memory CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Interleukin-15 rescues tolerant CD8+ T cells for use in adoptive immunotherapy of established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Critical role for IL-15 in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

IL-15 induces IFN-beta and iNOS gene expression, and antiviral activity of murine macrophage RAW 264.7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Overexpression of IL-15 in vivo enhances protection against Mycobacterium bovis bacillus Calmette-Guérin infection via augmentation of NK and T cytotoxic 1 responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Fatal leukemia in interleukin-15 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Interleukin-15 expression affects homeostasis and function of B cells through NK cell-derived interferon-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

IL-15 is a growth factor and an activator of CD8 memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Human natural killer cell development and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

Interleukin-15 as a potential regulator of the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

IL-7 and IL-15: therapeutic cytokines for immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0909648

21 January 2018

Identifiers

DOI

10.1189/JLB.0909648

1 reference

14 September 2017

1 reference